Marinus Pharmaceuticals, Inc. (MRNS) Social Stream



Marinus Pharmaceuticals, Inc. (MRNS): $1.33

0.03 (+2.31%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

C

Add MRNS to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#258 of 362

in industry

MARINUS PHARMACEUTICALS INC (MRNS) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering MARINUS PHARMACEUTICALS INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-12-06 9 $40 $20 $31 $10.26 202.14%
2022-02-02 9 $40 $20 $30.75 $10.26 199.71%
2022-02-22 9 $38 $20 $30.125 $10.26 193.62%
2022-02-23 9 $38 $17 $29.428 $10.26 186.82%
2022-03-23 8 $50 $17 $32.166 $10.26 213.51%
2022-03-28 8 $50 $17 $31.142 $10.26 203.53%
2022-04-01 8 $50 $17 $31.143 $10.26 203.54%
2022-05-17 8 $50 $17 $31.571 $10.26 207.71%
2022-08-12 8 $50 $17 $31 $10.26 202.14%
2022-10-31 8 $50 $17 $30.285 $10.26 195.18%
2022-11-09 9 $50 $17 $28.714 $10.26 179.86%
2022-11-14 9 $50 $12 $25.875 $10.26 152.19%
2023-01-23 7 $50 $12 $25.375 $10.26 147.32%
2023-03-08 8 $50 $12 $25.375 $10.26 147.32%
2023-04-20 10 $50 $12 $25 $10.26 143.66%
2023-04-25 10 $50 $14 $25.222 $10.26 145.83%
2023-05-15 11 $42 $14 $24.333 $10.26 137.16%
2023-07-11 11 $42 $14 $23.7 $10.26 130.99%
2023-08-11 11 $32 $14 $22.7 $10.26 121.25%
2023-09-19 11 $32 $9 $20.9 $10.26 103.7%
2023-09-21 11 $32 $9 $21.2 $10.26 106.63%
2023-11-08 11 $28 $9 $20.3 $10.26 97.86%

The Trend in the Analyst Price Target


MRNS's average price target has moved down $9.75 over the prior 23 months.

MRNS reports an average of 224.92% for its upside potential over the past 41 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-01-23 9 50 12 25.375 5.650 349.12%
2023-01-23 7 50 12 25.375 5.650 349.12%
2023-05-15 11 42 14 24.333 8.620 182.29%
2023-08-11 11 32 9 22.200 6.820 225.51%
2023-11-08 11 28 9 20.300 6.895 194.42%

MRNS Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.27 9 1 1 0 0 11

The Trend in the Broker Recommendations


MRNS's average broker recommendation rating worsened by 0.27 over the prior 16 months.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In terms of how MARINUS PHARMACEUTICALS INC fares relative to all US stocks, note that its variance in analysts' estimates is lower than -2525.23% of that group.
  • To contextualize these metrics, consider that out of all US stocks, MARINUS PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is greater than 2537.3% of them.
  • In terms of how MARINUS PHARMACEUTICALS INC fares relative to stocks in the small market cap category, note that its number of analysts covering the stock is greater than 2808.02% of that group.
  • To contextualize these metrics, consider that out of stocks in the small market cap category, MARINUS PHARMACEUTICALS INC's average analyst price target is higher than 2019.23% of them.

Stocks similar to MARINUS PHARMACEUTICALS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are AKBA, OCUL, and CRBP.

Make investment decisions regarding MRNS using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!